Cargando…
Development of a robust Escherichia coli-based cell-free protein synthesis application platform
Since the cell-free protein synthesis system is not limited by the cell growth, all the substrates are used to produce the protein of interest, and the reaction environment can be flexibly controlled. All the advantages allow it to synthesize toxic proteins, membrane proteins, and unnatural proteins...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568173/ https://www.ncbi.nlm.nih.gov/pubmed/33100890 http://dx.doi.org/10.1016/j.bej.2020.107830 |
_version_ | 1783596476053585920 |
---|---|
author | Jiang, Nan Ding, Xuanwei Lu, Yuan |
author_facet | Jiang, Nan Ding, Xuanwei Lu, Yuan |
author_sort | Jiang, Nan |
collection | PubMed |
description | Since the cell-free protein synthesis system is not limited by the cell growth, all the substrates are used to produce the protein of interest, and the reaction environment can be flexibly controlled. All the advantages allow it to synthesize toxic proteins, membrane proteins, and unnatural proteins that are difficult to make in vivo. However, one typical reason why the cell-free system has not been widely accepted as a practical alternative, is its expression efficiency problem. The Escherichia coli-based system was chosen in this study, and the model protein deGFP was expressed to explore a more efficient cell-free system. The results showed that Mg(2+) with a concentration of 15 mM in the cell-free system with BL21 Star (DE3) as the extract could better synthesize protein. The smaller the vectors, the lighter the burden, the higher the protein synthesis. Simulating the crowding effect in the cell does not improve the protein expression efficiency of the optimized cell-free protein synthesis system. Based on the optimized system, the cell-free fundamental research platform, primary screening platform, and portable biomolecular synthesis platform were established. This study provides a robust cell-free protein synthesis toolbox with easy extract preparation and high protein yield. It also enables more researchers to reap the benefits from the cell-free biosynthesis platform. |
format | Online Article Text |
id | pubmed-7568173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75681732020-10-19 Development of a robust Escherichia coli-based cell-free protein synthesis application platform Jiang, Nan Ding, Xuanwei Lu, Yuan Biochem Eng J Regular Article Since the cell-free protein synthesis system is not limited by the cell growth, all the substrates are used to produce the protein of interest, and the reaction environment can be flexibly controlled. All the advantages allow it to synthesize toxic proteins, membrane proteins, and unnatural proteins that are difficult to make in vivo. However, one typical reason why the cell-free system has not been widely accepted as a practical alternative, is its expression efficiency problem. The Escherichia coli-based system was chosen in this study, and the model protein deGFP was expressed to explore a more efficient cell-free system. The results showed that Mg(2+) with a concentration of 15 mM in the cell-free system with BL21 Star (DE3) as the extract could better synthesize protein. The smaller the vectors, the lighter the burden, the higher the protein synthesis. Simulating the crowding effect in the cell does not improve the protein expression efficiency of the optimized cell-free protein synthesis system. Based on the optimized system, the cell-free fundamental research platform, primary screening platform, and portable biomolecular synthesis platform were established. This study provides a robust cell-free protein synthesis toolbox with easy extract preparation and high protein yield. It also enables more researchers to reap the benefits from the cell-free biosynthesis platform. Elsevier B.V. 2021-01-15 2020-10-17 /pmc/articles/PMC7568173/ /pubmed/33100890 http://dx.doi.org/10.1016/j.bej.2020.107830 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Regular Article Jiang, Nan Ding, Xuanwei Lu, Yuan Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title | Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title_full | Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title_fullStr | Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title_full_unstemmed | Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title_short | Development of a robust Escherichia coli-based cell-free protein synthesis application platform |
title_sort | development of a robust escherichia coli-based cell-free protein synthesis application platform |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568173/ https://www.ncbi.nlm.nih.gov/pubmed/33100890 http://dx.doi.org/10.1016/j.bej.2020.107830 |
work_keys_str_mv | AT jiangnan developmentofarobustescherichiacolibasedcellfreeproteinsynthesisapplicationplatform AT dingxuanwei developmentofarobustescherichiacolibasedcellfreeproteinsynthesisapplicationplatform AT luyuan developmentofarobustescherichiacolibasedcellfreeproteinsynthesisapplicationplatform |